ASA Monitor May 2024, Vol. 88, 27. A study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) has found that women receiving mRNA-based COVID-19 vaccinations or boosters during pregnancy provide their infants with robust protection against symptomatic COVID-19 for at least six months after birth. The study underscores the importance of pregnant individuals […]
Read MoreAuthors: Vilma Joseph, MD, MPH, FASA et al ASA Monitor May 2024, Vol. 88, 33–35. In 2009, the ASA Committee on Professional Diversity (CPD) created the ASA Mentoring Grant. The CPD was chaired by Gregory Kerr, MD, MBA, and the inaugural director of the grant program was Karen Williams, MD. This grant was intended to foster […]
Read MoreASA Monitor May 2024, Vol. 88, 25. For which of the following local anesthetics is the duration of action MOST prolonged by the addition of epinephrine? (A) Bupivacaine (B) Lidocaine (C) Etidocaine Vasoconstrictors are added to local anesthetic solutions to decrease the rate of vascular absorption of local anesthetic deposited near the nerve. The added vasoconstrictor […]
Read MoreAuthors: Giacomo F. Scorsese, DO Jacob Nouriel, MD ASA Monitor May 2024, Vol. 88, 34–35. In general, the practice of anesthesiology and implementation of anesthetics have changed significantly since the days of the copper kettle and drop ether. Notable milestones in the 20th century included halogenated volatile anesthetics, intravenous induction drugs, carbon dioxide absorbents, continuous […]
Read MoreAuthors: Seyed A. Safavynia, MD, PhD; Shobana Rajan, MD, FASA ASA Monitor May 2024, Vol. 88, 28–29. Electroencephalographic (EEG) monitoring has become increasingly commonplace in the anesthesiologist’s practice since the Bispectral IndexTM (BISTM) Monitor (Medtronic) was approved by the U.S. Food and Drug Administration (FDA) in 1996 for monitoring anesthetic depth. Today, several other intraoperative EEG devices exist, […]
Read More